Current role of systemic therapy in transarterial chemotherapy refractory hepatocellular carcinoma patients
Transarterial chemotherapy (TACE) is the standard treatment for patients with intermediate-stage hepatocellular carcinoma (HCC), defined as large, unresectable, or multinodular HCC in patients with good functional performance. The definition of TACE refractoriness is not well established. Generally,...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Gastrointestinal Intervention
2021-10-01
|
| Series: | International Journal of Gastrointestinal Intervention |
| Subjects: | |
| Online Access: | http://journaleditor.inforang.com/journal/view.html?doi=10.18528/ijgii210046 |